R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

NCT01865110 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

623

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: R-CHOP
DRUG: R-CHOP / R-HAD
DRUG: Rituximab
DRUG: Lenalidomide

Sponsor

The Lymphoma Academic Research Organisation